Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
These drugs are divided into: incretinmimetics, derived from exendin-4 (a peptide obtained from the saliva of the Gila monster [Heloderma suspectum])
Minister Rists estimate of 100 million per year at full rollout implies a weighted average annual cost per treated patient of approximately 2,000 to 2,400 consistent with the maintenance-dose pricing of 195 per month
Eat protein
This lower dose is not intended to provide full glycaemic control but rather to allow the body to adjust to the medication and minimise gastrointestinal side effects
Other Ingredients: Vegetable cellulose (capsule), microcrystalline cellulose, organic rice flour, leucine
US$ 28.63
US$ 28.86
US$ 20.57
US$ 23.79
US$ 29.60
US$ 24.61
US$ 29.02
